Cabio
688089.SSCabio Biotech (Wuhan) Co., Ltd. Price (688089.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
169,211,417
(0.7211)%Revenue and Profitability
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 200,055,049 | 186,529,524 | 181,157,274 | 189,803,140 | 228,559,194 | 286,105,570 | 311,547,812 | 323,460,668 | 351,109,348 | 433,424,477 | 443,803,122 |
| Net Income | 46,701,983 | 37,659,781 | 19,545,316 | 46,963,433 | 65,779,061 | 96,986,038 | 118,173,427 | 130,585,376 | 128,578,881 | 64,371,911 | 91,374,165 |
| FCF USD | 23,453,412 | 25,438,260 | 22,928,894 | 46,325,940 | 77,503,908 | 93,822,198 | 108,674,106 | 112,783,795 | -70,137,663 | -73,065,100 | -228,790,423 |
| OCF USD | 39,480,700 | 46,341,800 | 44,581,500 | 62,531,823 | 100,663,698 | 106,162,572 | 131,947,334 | 145,882,192 | 103,291,182 | 176,402,734 | 68,888,874 |
Financial Health - DEBT
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.01 |
| D/E | 0.00 | 0.02 | 0.17 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 |
| CA/CL | 5.85 | 7.26 | 2.71 | 3.89 | 8.34 | 7.41 | 26.36 | 21.47 | 16.59 | 5.03 | 6.30 |
| TA/TL | 11.79 | 12.22 | 5.14 | 6.43 | 12.06 | 10.57 | 26.89 | 23.32 | 21.72 | 8.67 | 13.70 |
| Total Debt | 0 | 11,000,000 | 59,000,000 | 40,000,000 | 0 | 0 | 0 | 0 | 2,418,212 | 33,046,083 | 11,672,603 |
Management Performance
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | 10.19% | 8.29% | 3.02% | 6.27% | 9.19% | 13.11% | 9.79% | 7.99% | 7.29% | 7.26% | 4.67% |
| ROE | 10.91% | 8.08% | 5.51% | 11.64% | 14.13% | 18.42% | 9.47% | 9.91% | 9.31% | 4.54% | 6.19% |
| ROA | 0.00% | 7.42% | 4.44% | 9.72% | 12.95% | 16.83% | 9.23% | 9.76% | 9.06% | 3.82% | 5.67% |
| NM % | 23.34% | 20.19% | 10.79% | 24.74% | 28.78% | 33.90% | 37.93% | 40.37% | 36.62% | 14.85% | 20.59% |
| FCF / R% | 0.00% | 13.64% | 12.66% | 24.41% | 33.91% | 32.79% | 34.88% | 34.87% | -19.98% | -16.86% | -51.55% |
| FCF / NI% | 50.22% | 67.55% | 117.31% | 99.94% | 118.17% | 95.90% | 90.75% | 83.58% | -53.42% | -118.64% | -250.39% |
| Operating Margin (OM) | 0.00 | 1.59 | 0.06 | 0.27 | 0.48 | 0.57 | 0.72 | 0.87 | 1.02 | 0.87 | 0.95 |
Per Share
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 0.53 | 0.42 | 0.16 | 0.37 | 0.52 | 0.77 | 0.70 | 0.78 | 0.77 | 0.38 | 0.54 |
| SPS | 2.25 | 2.10 | 1.46 | 1.50 | 1.81 | 2.28 | 1.85 | 1.93 | 2.09 | 2.58 | 2.62 |
| OCPS | 0.44 | 0.52 | 0.36 | 0.49 | 0.80 | 0.84 | 0.79 | 0.87 | 0.61 | 1.05 | 0.41 |
| FCPS | 0.26 | 0.29 | 0.18 | 0.37 | 0.61 | 0.75 | 0.65 | 0.67 | -0.42 | -0.43 | -1.35 |
| BVPS | 4.82 | 5.24 | 2.85 | 3.18 | 3.68 | 4.19 | 7.44 | 7.88 | 8.23 | 8.48 | 8.83 |
Per Share - CAGR
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.53 | 0.42 | 0.16 | 0.37 | 0.52 | 0.77 | 0.70 | 0.78 | 0.77 | 0.38 | 0.54 |
| CAGR-SPS | 2.25 | 2.10 | 1.46 | 1.50 | 1.81 | 2.28 | 1.85 | 1.93 | 2.09 | 2.58 | 2.62 |
| CAGR-OCPS | 0.44 | 0.52 | 0.36 | 0.49 | 0.80 | 0.84 | 0.79 | 0.87 | 0.61 | 1.05 | 0.41 |
| CAGR-FCPS | 0.26 | 0.29 | 0.18 | 0.37 | 0.61 | 0.75 | 0.65 | 0.67 | -0.42 | -0.43 | -1.35 |
| CAGR-BVPS | 4.82 | 5.24 | 2.85 | 3.18 | 3.68 | 4.19 | 7.44 | 7.88 | 8.23 | 8.48 | 8.83 |